ARCHIVES

FDA Promises No More IND Disruptions Without “Very Valid Reasons,” Nears Agreement With NCI

This article is from The Cancer Letter archive.

Vol. 03 No. 15 | April 15, 1977

Download PDF Visit The Full Archive

Related Articles

CTRC Wins Renewal Of Cancer Center Grant; New Mexico To Lead Systems Biology Center

September 4, 2009

Recalcitrant Cancer Bill Heading To Senate May Face Hold in the Lame Duck Session

November 16, 2012

ASCO proposes compromise to limit payment cuts proposed by Congress, CMS.

September 12, 2003

Some Tumors Show Partial Response To Drug Combo

January 27, 2006

NCI Programs: NCI To Study Colorectal Cancer Screening Practices

September 17, 1999

FDA Committee to Discuss Policy On Combinations

January 7, 1977